Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway

Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway

(1) Background: Ginsenoside Rb1-PLGA nanoparticles (GRb1@PLGA@NPs) represent a novel nanotherapeutic system, yet their therapeutic efficacy and underlying mechanisms for treating heart failure (HF) remain unexplored. This study aims to investigate the potential mechanisms underlying the therapeutic...

Full description

Bibliographic Details
Main Authors: Lixin Du, Huiling Lu, Ziyan Wang, Chengxin Liu, Yifei Xiao, Zhihua Guo, Ya Li
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Molecules
Subjects:
ginsenoside Rb1
nanoparticles
heart failure
oxidative stress
ROS/PPARα/PGC1α
Online Access:https://www.mdpi.com/1420-3049/28/24/8118

Internet

https://www.mdpi.com/1420-3049/28/24/8118

Similar Items